(PharmaNewsWire.Com, December 06, 2023 ) As per Maximize Market research, the GI Stool TestingMarket was USD 790.45 Million in 2022 and is expected to grow at a CAGR of 7.23 percent over the forecast period to reach USD 1288.51 Million by 2029.
The GI Stool Testing Market Report has comprehensive methodologies using primary and secondary sources, data collection, and expert insights to explore market segmentation, regional analysis, and future prospects.
The GI Stool Testing Market is experiencing growth due to increasing consumer awareness of its health benefits, such as antioxidants and vitamin content. Rising demand for natural and functional ingredients in the food and beverage industry, along with its application in traditional medicine, is propelling market expansion.
GI Stool Testing Market Regional Insights
North America dominates the GI Stool Testing market due to rising colon cancer and GERD cases. The region is expected to hold the largest market share, with the United States being a major contributor to the market's growth.
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: